Our results suggested that DNMT1 functioned as one of downstream effectors of SP1 and PDPK1, and that reduction in DNMT1 was involved in the BBR‐inhibited NSCLC cell growth. This evidence concerns the gene DNMT1 and non-small cell lung carcinoma.